RTI-229

RTI-229 is a tropane derivative drug that acts as a dopamine reuptake inhibitor and has been researched for use in treating cocaine addiction. It is a potent and selective DAT inhibitor, with a Ki of 0.16 nM, and is around 5x more potent than cocaine at inhibiting dopamine reuptake, although it produces significantly less locomotor stimulation in animals. It is named after the Research Triangle Institute (RTI), and is part of the phenyltropane group of compounds.

Pharmacology

RTI-229 is a phenyltropane based, highly potent and selective DAT inhibitor. It is around 5x more potent than cocaine at inhibiting dopamine reuptake. However, it produces significantly less locomotor stimulation in animals, which suggests a lower potential for recreational use.

Potential Medical Uses

RTI-229 has been researched for use in treating cocaine addiction. The drug's high potency and selectivity for the DAT over other targets make it a promising candidate for this application. However, further research is needed to fully understand its potential benefits and risks.

See Also

• RTI-31
• RTI-32
• RTI-51
• RTI-55
• RTI-112
• RTI-113
• RTI-121
• RTI-126
• RTI-150
• RTI-177
• RTI-336
• RTI-371

RTI-229 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski